People having hematological disorders and hypercoagulability state need extra precautions because of the increased risk of thrombosis after COVID-19 vaccination

People having hematological disorders and hypercoagulability state need extra precautions because of the increased risk of thrombosis after COVID-19 vaccination

Bibliographic Details
Main Authors:	Duygu Aydemir, Nuriye Nuray Ulusu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Medicine
Subjects:	hematological disorders thrombosis hypercoagulability COVID-19 vaccination
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1082611/full

Similar Items

The possible importance of the antioxidants and oxidative stress metabolism in the emerging monkeypox disease: An opinion paper
by: Duygu Aydemir, et al.
Published: (2022-10-01)

The possible role of the endocrine disrupting chemicals on the premature and early menopause associated with the altered oxidative stress metabolism
by: Duygu Aydemir, et al.
Published: (2023-02-01)

The impact of the endocrine-disrupting chemicals on the glucose-6-phosphate dehydrogenase enzyme activity
by: Duygu Aydemir, et al.
Published: (2023-03-01)

Evaluation of the Hematological and Serum Biochemistry Parameters in the Pre-Symptomatic and Symptomatic Stages of ALS Disease to Support Early Diagnosis and Prognosis
by: Duygu Aydemir, et al.
Published: (2022-11-01)

Effects of the in-utero dicyclohexyl phthalate and di-n-hexyl phthalate administration on the oxidative stress-induced histopathological changes in the rat liver tissue correlated with serum biochemistry and hematological parameters
by: Duygu Aydemir, et al.
Published: (2023-05-01)

Evaluation of the Cell Behavior and Growth Characteristics of the Porcine Dermal Xenograft Patch in Relation to the Surface Properties
by: Duygu Aydemir, et al.
Published: (2022-05-01)

Dataset of the analyzing trace elements and minerals via ICP-MS: Method validation for the mammalian tissue and serum samples
by: Duygu Aydemir, et al.
Published: (2020-04-01)

Impact of the Amyotrophic Lateral Sclerosis Disease on the Biomechanical Properties and Oxidative Stress Metabolism of the Lung Tissue Correlated With the Human Mutant SOD1G93A Protein Accumulation
by: Duygu Aydemir, et al.
Published: (2022-02-01)

Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part I. The pathophysiology of thrombosis and hypercoagulation
by: E. N. Lipets, et al.
Published: (2015-10-01)

Data the DEHP induced changes on the trace element and mineral levels in the brain and testis tissues of rats
by: Duygu Aydemir, et al.
Published: (2019-10-01)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
by: Sinda Zarrouk, et al.
Published: (2021-09-01)

Hypercoagulable workup in a community hospital setting: to test or not to test; that is the question
by: Ashish Gupta, et al.
Published: (2019-09-01)

Characteristics of Laboratory Biomarkers Associated with Hypercoagulability in Lung Cancer Patients During Perioperative Period and Its Diagnostic Value for Deep Venous Thrombosis
by: FANG Qiang, et al.
Published: (2019-12-01)

Cerebral Venous Sinus Thrombosis induced By Hypercoagulation in Patient With Systemic Lupus Erythematosus: A Case Report and Literature Review
by: Amalia L
Published: (2023-01-01)

Right transverse sinus thrombosis and bilateral PCA stroke in a patient with a hypercoagulable state
by: Georgiana Mares, et al.
Published: (2013-12-01)

Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction
by: Siyu Jiang, et al.
Published: (2022-09-01)

Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part II. The sensitivity of integral tests to hypercoagulable states
by: E. N. Lipets, et al.
Published: (2015-10-01)

Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis
by: Yanglan He, et al.
Published: (2021-06-01)

Editorial: The effect of COVID-19 on hematological disease diagnosis, management and outcomes
by: Mohamed Yassin, et al.
Published: (2023-04-01)

Inferior Vena Cava Thrombus due to Left Inferior Vena Cava and Ulcerative Colitis
by: Hirofumi Arai, et al.
Published: (2018-10-01)

Relationship between systemic inflammatory response and hypercoagulation in patients with immuno-inflammatory rheumatic diseases
by: Yu. A. Zhuravleva, et al.
Published: (2023-06-01)

Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis
by: Sana Ayyoub, et al.
Published: (2023-01-01)

Cerebral venous sinus thrombosis in pregnancy and puerperium: A comprehensive review
by: Hussein Algahtani, et al.
Published: (2022-01-01)

Rotational thromboelastometry in critically ill COVID‐19 patients does not predict thrombosis
by: Romein W. G. Dujardin, et al.
Published: (2022-08-01)

Study on risk of hypercoagulation in patients with obstructive sleep apnea
by: Amany Omar, et al.
Published: (2021-01-01)

Effects of timolol treatment on pancreatic antioxidant enzymes in streptozotocin-induced diabetic rats: An experimental and computational study
by: Nuray Ulusu Nuriye, et al.
Published: (2019-01-01)

Trends of Ordering Hypercoagulability Work-Up at an Academic Medical Center
by: Alidoost M, et al.
Published: (2021-05-01)

Ischemic lesions in all territories as a marker of malignant hypercoagulability
by: Claus Z. Simonsen, et al.
Published: (2019-07-01)

Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels
by: O. Ya. Porembskaya, et al.
Published: (2022-09-01)

Popliteal arterial thrombosis in nephrotic syndrome: a case report
by: Niranjan Tachamo, et al.
Published: (2017-01-01)

Anticoagulant effect of Huisheng Oral Solution in a rat model of thrombosis
by: Liu Shuang-Qing, et al.
Published: (2013-01-01)

Chronometric vs. Structural Hypercoagulability
by: Carmen Delianu, et al.
Published: (2020-12-01)

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
by: Eser Mehmet, et al.
Published: (2012-08-01)

Cerebral venous thrombosis in otorhinolaryngology. Case report
by: Aleksandr A. Krivopalov, et al.
Published: (2022-09-01)

New capabilities of laboratory diagnosis of thromboses
by: A. A. Shabalina, et al.
Published: (2017-02-01)

Renal artery thrombosis in SARS-CoV-2 infection: a case report
by: Huayan Huang, et al.
Published: (2022-05-01)

Research progress on hypercoagulable state in patients with acromegaly
by: MA Li-yuan, GUO Xiao-peng, XING Bing
Published: (2020-10-01)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
by: Alberto Zanetto, et al.
Published: (2018-11-01)

Delayed hypercoagulable state in COVID‐19 adolescent patient: a case report
by: Desdiani Desdiani, et al.
Published: (2021-07-01)

Pathogenesis of Malignant Tumor with Hypercoagulable State in Traditional Chinese Medicine and Western Medicine
by: FU Danli, et al.
Published: (2018-03-01)